Literature DB >> 9885981

Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma.

M Kirchhoff1, H Rose, B L Petersen, J Maahr, T Gerdes, C Lundsteen, T Bryndorf, N Kryger-Baggesen, L Christensen, S A Engelholm, J Philip.   

Abstract

We analyzed 17 cases of dysplasia/carcinoma in situ (CIS) of the cervix and 29 advanced-stage cervical squamous cell carcinomas by comparative genomic hybridization (CGH). A comparable recurrent pattern of aberrations was detected in both preinvasive and invasive cases, although the total number of aberrations was much higher in the latter category. The most consistent chromosomal gain was mapped to chromosome arm 3q in 35% of preinvasive cases and in 72% of invasive cases. Chromosome aberrations were detected in 13/17 preinvasive cases with a total of 61 involved chromosome arms. In the invasive cases, frequent gains also occurred on 1q (45%), 8q (41%), 15q (41%), 5p (34%), and Xq (34%), and frequent losses were mapped to chromosome arms 3p (52%), 11q (48%), 13q (38%), 6q (38%), and 4p (34%). A recurrent pattern of aberrations has not previously been described in preinvasive lesions of the cervix. Our finding is surprising considering that only few preinvasive lesions are expected to progress to invasive cancer.

Entities:  

Mesh:

Year:  1999        PMID: 9885981     DOI: 10.1002/(sici)1098-2264(199902)24:2<144::aid-gcc7>3.0.co;2-9

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  35 in total

1.  Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

Authors:  Sonia Andersson; Pavani Sowjanya; Darawalee Wangsa; Anders Hjerpe; Bo Johansson; Gert Auer; Patti E Gravitt; Catharina Larsson; Keng-Ling Wallin; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Am J Pathol       Date:  2009-11       Impact factor: 4.307

2.  BIRC2 amplification in squamous cell carcinomas of the uterine cervix.

Authors:  M Choschzick; A M Tabibzada; F Gieseking; L Woelber; F Jaenicke; G Sauter; R Simon
Journal:  Virchows Arch       Date:  2012-06-26       Impact factor: 4.064

3.  Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.

Authors:  Kerstin Heselmeyer-Haddad; Kathrin Sommerfeld; Nicole M White; Nadia Chaudhri; Larry E Morrison; Nallasivam Palanisamy; Zhen Yuan Wang; Gert Auer; Winfried Steinberg; Thomas Ried
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  Genomic aberrations in borderline ovarian tumors.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Hege K Andersen; Vera M Abeler; Ben Davidson; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Transl Med       Date:  2010-02-26       Impact factor: 5.531

5.  Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer.

Authors:  Mónica Mendoza-Rodriguez; Hugo Arreola; Alejandra Valdivia; Raúl Peralta; Humberto Serna; Vanessa Villegas; Pablo Romero; Beatriz Alvarado-Hernández; Lucero Paniagua; Daniel Marrero-Rodríguez; Marco A Meraz; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Chromosomal aberrations accumulate in polyploid cells of high-grade squamous intraepithelial lesions (HSIL).

Authors:  Gábor Méhes; Norbert Speich; Magdolna Bollmann; Reinhard Bollmann
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

7.  High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.

Authors:  K J Purdie; C A Harwood; K Gibbon; T Chaplin; B D Young; J B Cazier; N Singh; I M Leigh; C M Proby
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

8.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 9.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

10.  Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.

Authors:  Malin Lando; Marit Holden; Linn C Bergersen; Debbie H Svendsrud; Trond Stokke; Kolbein Sundfør; Ingrid K Glad; Gunnar B Kristensen; Heidi Lyng
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.